6 completed, 3 recruiting, 2 not yet recruiting, 2 unknown. 4 Not applicable, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Active not recruiting 1, Completed 1, Unknown 1, Withdrawn 1 |
| Phase 4 | 2 | Recruiting 2 |
Follow Major Adverse Cardiac Events: new trials by email Literature Review of Major Adverse Cardiac Events trials Research Report on Major Adverse Cardiac Events
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIAL Tofacitinib 5 MG - Rheumatoid Arthritis, Major Adverse Cardiac Events | Phase 4 | Recruiting | Shaikh Zayed Hospital, Lahore | 120 | 2025-12-06 | 2026-04-28 |
| TTE Improves Clinical Management of Stable Chest Pain TTE - Transthorcic Echocardiography, Stable Angina Pectoris | Recruiting | Tianjin Chest Hospital | 50000 | 2025-01-01 | 2025-07-18 | |
| Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data Tirzepatide, Dulaglutide - Type 2 Diabetes, Major Adverse Cardiac Events | Completed | Brigham and Women's Hospital | 44671 | 2024-10-01 | 2025-10-15 | |
| Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation low-dose rivaroxaban, Standard-dose rivaroxaban - Atrial Fibrillation, Anticoagulant Adverse Reaction | Phase 4 | Recruiting | China National Center for Cardiovascular Diseases | 4374 | 2024-09-01 | 2024-09-19 |
| Impact of Assessment and Management of Comorbidities in Internal Medicine on Cardiovascular Risk Screening and management of cormobidities - Adverse Cardiac Event, Major Adverse Cardiac Events | Not applicable | Active not recruiting | University Hospital, Montpellier | 70 | 2024-05-21 | 2026-09-24 |
| Study on the Serum Metabolic Markers and Early Complications After Allo-HSCT: Cohort Study Serum metabolomics sequencing - Stem Cell Transplant Complications, Acute Graft Versus Host Disease | Not yet recruiting | First Affiliated Hospital Xi'an Jiaotong University | 500 | 2024-05-01 | 2024-04-26 | |
| Effect of Patient Management Based on Continuous Continuous Glucose Monitoring on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes and Moderate to Severe Coronary Artery Stenosis CGM - Diabetes Mellitus, Type 2, Major Adverse Cardiac Events | Not applicable | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 4000 | 2024-01-01 | 2023-09-29 |
| Novel Cardiovascular Biomarkers in Patients With Kidney Disease Cardiac Biomarkers, Lipidomics, Proteomics - Haemodialysis Complication, Major Adverse Cardiac Events | Not yet recruiting | Liverpool University Hospitals NHS Foundation Trust | 100 | 2023-11-01 | 2023-09-18 | |
| Predictive Value of NT-proBNP on MACEs After Acute Coronary Syndrome N-terminal pro-B-type natriuretic peptide (NT-proBNP), high sensitive cardiac troponin T (hs-cTnT) - Acute Coronary Syndrome, ST-segment Elevation Myocardial Infarction (STEMI) | Completed | Haseki Training and Research Hospital | 241 | 2023-09-01 | 2024-08-26 | |
| Construction of a Prediction Model for MACCE in Elderly Patients After Elective Non-cardiac Surgery Revised Cardiac Risk Index - Major Adverse Cardiac Events, Cerebrovascular Accident | Unknown | Beijing Tsinghua Chang Gung Hospital | 3000 | 2023-03-01 | 2024-04-30 | |
| Adverse Events in Acute Limb Ischemic Patient Undergoing Revascularization Major Adverse Cardiac Events, Adverse Effect of Unspecified General Anesthetic | Completed | Mahidol University | 240 | 2022-04-10 | 2026-10-14 | |
| Colchicine Prevents Myocardial Injury After Non-Cardiac Surgery Pilot Study Colchicine 0.6 mg, Placebo oral tablet - Myocardial Infarction, Myocardial Injury | Not applicable | Withdrawn | University of British Columbia | 2020-09-01 | 2021-11-19 | |
| Impact of OSA on Outcomes in Acute Coronary Syndrome ApneaLink Type III portable sleep study - OSA, ACS - Acute Coronary Syndrome | Completed | MetroHealth Medical Center | 128 | 2017-08-29 | 2020-12-14 | |
| Preoperative Cardiology Consultation and the Incidence of Major Adverse Cardiac Events(MACE) Major Adverse Cardiac Events, Acute Myocardial Infarction (AMI) | Completed | Chinese PLA General Hospital | 22000 | 2015-01-01 | 2025-03-28 | |
| Echo-guided Hemodynamic Management Strategy in Elderly Patients Undergoing Noncardiac Surgery EGHEM - Ventricular Dysfunction, Left, Major Adverse Cardiac Events | Not applicable | Completed | University of Nebraska | 97 | 2014-09-01 | 2023-09-15 |
Cardiovascular Diseases (15) · Acute Coronary Syndrome (2) · Diabetes Mellitus, Type 2 (2) · Stroke (2) · Acute Kidney Injury (1) · Angina, Stable (1) · Angina, Unstable (1) · Arrhythmias, Cardiac (1) · Arthritis, Rheumatoid (1) · Atrial Fibrillation (1) · Coronary Artery Disease (1) · Death, Sudden, Cardiac (1) · Heart Arrest (1) · Heart Failure (1) · Kidney Failure, Chronic (1)
Heart Diseases (7) · Pathological Conditions, Signs and Symptoms (7) · Vascular Diseases (7) · Pathologic Processes (6) · Myocardial Ischemia (5) · Angina Pectoris (2) · Brain Diseases (2) · Central Nervous System Diseases (2) · Cerebrovascular Disorders (2) · Chest Pain (2) · Diabetes Mellitus (2) · Endocrine System Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Glucose Metabolism Disorders (2)
Colchicine (1) · Hydroxymethylglutaryl-CoA Reductase Inhibitors (1) · Mass Screening (1) · Rivaroxaban (1) · Tirzepatide (1) · dulaglutide (1) · tofacitinib (1)
Beijing Tsinghua Chang Gung Hospital (1) · Brigham and Women's Hospital (1) · China National Center for Cardiovascular Diseases (1) · Chinese PLA General Hospital (1) · First Affiliated Hospital Xi'an Jiaotong University (1) · Haseki Training and Research Hospital (1) · Liverpool University Hospitals NHS Foundation Trust (1) · Mahidol University (1) · MetroHealth Medical Center (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · Shaikh Zayed Hospital, Lahore (1) · Tianjin Chest Hospital (1) · University Hospital, Montpellier (1) · University of British Columbia (1) · University of Nebraska (1)
China (5) · United States (3) · Canada (1) · France (1) · Pakistan (1) · Thailand (1) · Turkey (Türkiye) (1)
Adem Az, M.D. (1) · Aflak Rasheed, FCPS (1) · Anirudh Rao, PhD (1) · Dennis Auckley, MD (1) · Huan Zhang, PhD (1) · Jingsheng Lou, PhD & MD (1) · Maira Khalil, MBBS (1) · Masooma Hashmat, FCPS (1) · Ron Ree, MD (1) · Sasha K Shillcutt, MD (1) · Shirley Wang, PhD, ScM (1)
PMID 27703287, PMID 30249382, PMID 30916200, PMID 32272883, PMID 32692391, PMID 33092804, PMID 33605111, PMID 34765262, PMID 40675206, PMID 41207920